Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. | Cancers (Basel) | 2022 | 36291806 | PubTator, text mining | PubMed |
| The Proliferating Cell Nuclear Antigen (PCNA) Transcript Variants as Potential Relapse Markers in B-Cell Acute Lymphoblastic Leukemia. | Cells | 2022 | 36291073 | PubTator, text mining | PubMed |
| Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside. | Biomedicines | 2022 | 36289774 | PubTator, text mining | PubMed |
| Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma. | Biomedicines | 2022 | 36289681 | PubTator, text mining | PubMed |
| Feline Oncogenomics: What Do We Know about the Genetics of Cancer in Domestic Cats? | Vet Sci | 2022 | 36288160 | PubTator, text mining | PubMed |
| Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients. | Front Genet | 2022 | 36267410 | PubTator, text mining | PubMed |
| Erdheim-Chester disease: Typical radiologic findings of a multisystemic disease. | Radiol Case Rep | 2022 | 36263330 | PubTator, text mining | PubMed |
| PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma. | Front Immunol | 2022 | 36263036 | PubTator, text mining | PubMed |
| Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC. | JTO Clin Res Rep | 2022 | 36247019 | PubTator, text mining | PubMed |
| NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer. | J Oncol | 2022 | 36245981 | PubTator, text mining | PubMed |
| Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells. | Cells | 2022 | 36230903 | PubTator, text mining | PubMed |
| Potential methylation-regulated genes and pathways in hepatocellular neoplasm, not otherwise specified. | Front Oncol | 2022 | 36212481 | PubTator, text mining | PubMed |
| Human papillomavirus-related neoplasia of the ocular adnexa. | Acta Ophthalmol | 2022 | 36203222 | PubTator, text mining | PubMed |
alpha2,3 sialic acid processing enzymes expression in gastric cancer tissues reveals that ST3Gal3 but not Neu3 are associated with Lauren's classification, angiolymphatic invasion and histological grade. | Eur J Histochem | 2022 | 36172711 | PubTator, text mining | PubMed |
| Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | Elife | 2022 | 36169302 | PubTator, text mining | PubMed |
| Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases. | Case Rep Endocrinol | 2022 | 36160179 | PubTator, text mining | PubMed |
| Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. | Front Oncol | 2022 | 36158685 | PubTator, text mining | PubMed |
| The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells. | Oncogene | 2022 | 36153370 | PubTator, text mining | PubMed |
| Cellular Lipids-Hijacked Victims of Viruses. | Viruses | 2022 | 36146703 | PubTator, text mining | PubMed |
| Mortality-to-Incidence Ratio for Nasopharyngeal Carcinoma Is Associated with Health Expenditure. | Healthcare (Basel) | 2022 | 36141227 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=13